Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
12.04x1.08x0.42x1.81x7.29x9.85x2.84% 628.54Cr
17.84x2.03x-2.16x3.86x10.13x11.56x0.57% 6.91TCr
25.52x3.85x1.88x5.27x15.47x19.18x0.62% 5.18TCr
34.53x6.94x0.67x11.71x22.37x26.07x-.--% 4.36TCr
-45.77x2.51x0.35x3.23x9.55x11.15x3.34% 4.09TCr
24.82x1.66x-5.84x3.61x12.09x13.71x-.--% 3.08TCr
-7.29x4.42x-0.38x10.33x-6.35x-5.96x-.--% 2.51TCr
41.68x - -0.74x - - - -.--% 2.33TCr
68.08x6.12x0.44x6.73x46.32x52.25x-.--% 2.09TCr
24.41x3.5x0.02x5.19x13.22x18.57x-.--% 1.67TCr
-36.59x-6.4x0.87x17.25x-47.16x-54.34x-.--% 1.57TCr
-114.9x12555.08x2.61x12.35x-88.4x-123.26x-.--% 1.22TCr
17.7x - 0.2x3.64x14.09x15.9x-.--% 1.16TCr
45.1x - 4.17x - - - -.--% 1.01TCr
50.59x20.63x0.48x30.53x43.18x44.53x0.18% 999.82Cr
71.22x5.04x-0.92x - - - - 675.82Cr
29.87x - 1.47x8.06x21.39x25.54x0.35% 609.8Cr
14.22x1.31x-0.21x2.5x6.48x7.84x1.59% 571.32Cr
-45.07x - -0.81x - - - - 568.1Cr
-113.6x - 7.53x - - - -.--% 558.1Cr
Average 5.72x 900.55x 0.50x 8.40x 5.31x 4.84x 0.53% 2.09TCr
Weighted average by Cap. 11.23x 434.20x -0.17x 7.16x 8.89x 9.81x 0.59%
Biopharmaceuticals